Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Emberton

Showing results (241-250 of 474) with videos related to

Pageof 48
Sort By:
European Urology|June 30, 2012
Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic reviewCaroline M Moore, Nicola L Robertson, Nasr Arsanious, et al.
International Journal of Molecular Sciences|April 30, 2021
Tissue-Engineering the Fibrous Pancreatic Tumour Stroma Capsule in 3D Tumouroids to Demonstrate Paclitaxel ResponseJudith Pape, Katerina Stamati, Rawiya Al Hosni, et al.
European Urology|June 1, 2021
Mapping Contemporary Biopsy Zones to Traditional Prostatic Anatomy: The Key to Understanding Relationships Between Prostate Cancer Topography, Magnetic Resonance Imaging Conspicuity, and Clinical RiskPranav Satish, Benjamin Simpson, Alex Freeman, et al.
Journal of Tissue Engineering|June 4, 2020
The anti-angiogenic tyrosine kinase inhibitor Pazopanib kills cancer cells and disrupts endothelial networks in biomimetic three-dimensional renal tumouroidsKaterina Stamati, Patricia A Redondo, Agata Nyga, et al.
BJU International|January 20, 2012
Novel approaches to improve prostate cancer diagnosis and management in early-stage diseaseMichael Marberger, Jelle Barentsz, Mark Emberton, et al.
BJU International|February 12, 2005
Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunctionR Jeroen A van Moorselaar, Rudolf Hartung, Mark Emberton, et al.
European Urology|October 12, 2004
EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines)Stephan Madersbacher, Gerasimos Alivizatos, Jorgen Nordling, et al.
European Radiology|April 2, 2026
Reply to the Letter to the Editor: Variation in prostate cancer growth rates in an MRI-based active surveillance cohortHayley Smith, Vasilis Stavrinides, Francesco Giganti, et al.
BJU International|March 7, 2008
Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practiceGuy Vallancien, Mark Emberton, Antonio Alcaraz, et al.
European Radiology|January 16, 2026
Variation in prostate cancer growth rates in an MRI-based active surveillance cohortHayley Smith, Vasilis Stavrinides, Francesco Giganti, et al.
Pageof 48

Showing results (241-250 of 474) with videos related to

Sort By:
Pageof 48
European Urology|June 30, 2012
Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic reviewCaroline M Moore, Nicola L Robertson, Nasr Arsanious, et al.
International Journal of Molecular Sciences|April 30, 2021
Tissue-Engineering the Fibrous Pancreatic Tumour Stroma Capsule in 3D Tumouroids to Demonstrate Paclitaxel ResponseJudith Pape, Katerina Stamati, Rawiya Al Hosni, et al.
European Urology|June 1, 2021
Mapping Contemporary Biopsy Zones to Traditional Prostatic Anatomy: The Key to Understanding Relationships Between Prostate Cancer Topography, Magnetic Resonance Imaging Conspicuity, and Clinical RiskPranav Satish, Benjamin Simpson, Alex Freeman, et al.
Journal of Tissue Engineering|June 4, 2020
The anti-angiogenic tyrosine kinase inhibitor Pazopanib kills cancer cells and disrupts endothelial networks in biomimetic three-dimensional renal tumouroidsKaterina Stamati, Patricia A Redondo, Agata Nyga, et al.
BJU International|January 20, 2012
Novel approaches to improve prostate cancer diagnosis and management in early-stage diseaseMichael Marberger, Jelle Barentsz, Mark Emberton, et al.
BJU International|February 12, 2005
Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunctionR Jeroen A van Moorselaar, Rudolf Hartung, Mark Emberton, et al.
European Urology|October 12, 2004
EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines)Stephan Madersbacher, Gerasimos Alivizatos, Jorgen Nordling, et al.
European Radiology|April 2, 2026
Reply to the Letter to the Editor: Variation in prostate cancer growth rates in an MRI-based active surveillance cohortHayley Smith, Vasilis Stavrinides, Francesco Giganti, et al.
BJU International|March 7, 2008
Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practiceGuy Vallancien, Mark Emberton, Antonio Alcaraz, et al.
European Radiology|January 16, 2026
Variation in prostate cancer growth rates in an MRI-based active surveillance cohortHayley Smith, Vasilis Stavrinides, Francesco Giganti, et al.
Pageof 48